You are here: Industry Insights > Roche

News List

Roche’s SARS-CoV-2 Test Receives EUA contractpharma
March 16, 2020
First commercial test for SARS-CoV-2 will enable expedited coronavirus testing with results in three and half hours.
Ten drugs in pre-registration phase have potential to reach blockbuster status by 2025: GlobalData expresspharma
March 13, 2020
Amgen and Allergan’s biosimilar candidate to Roche’s Rituxan (rituximab) shows the greatest potential of these drugs.
Biotech company Promedior merges with Roche europeanpharmaceuticalreview
March 11, 2020
Roche has successfully completed its purchase of Promedior, Inc. along with its entire portfolio of fibrotic disease therapeutics.
China approves use of Roche arthritis drug for some Covid-19 patients expresspharma
March 05, 2020
Tocilizumab, sold by the Swiss pharma giant under the trade name Actemra, can be prescribed to coronavirus patients who show serious lung damage.
Roche HER2-ADC Enmetrastuzumab has been approved for marketing in China En-CPhI.CN
January 19, 2020
Detailed story will be updated soon, please stay tuned with us.
ProBioGen Inks Next Commercial GlymaxX® License with Roche b3cnewswire
January 16, 2020
ProBioGen AG has signed a commercial license agreement with Roche for applying ProBioGen’s proprietary GlymaxX® technology to boost the antibody’s ADCC anti-tumor activity.
Roche and Illumina partner to broaden patient access to genomic testing worldpharmanews
January 15, 2020
Roche has entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based testing in oncology.
Roche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapy worldpharmanews
December 20, 2019
Roche and Spark Therapeutics, Inc. announced the completion of the acquisition following the receipt of regulatory approval from all government authorities required by the merger agreement.
Roche’s Ph III cancer immunotherapy trial reveals positive results for liver cancer biospectrumasia
December 18, 2019
The IMbrave150 study combination immunotherapy, with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab, has proven positive results by enhancing the potential of the immune system to combat Hepatocellular Carcinoma (HCC) among Asian pati
Roche launches Cobas Zika blood screening test biospectrumasia
December 18, 2019
Cobas Zika test expands Roche's industry-leading donor screening portfolio for blood-borne diseases in the CE market.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page